These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14287942)

  • 1. ACTIVITY OF AMPICILLIN ALONE AND IN COMBINATION WITH CHLORAMPHENICOL OR STREPTOMYCIN AGAINST PROTEUS MIRABILIS IN VIVO AND IN VITRO.
    STRAUS AL; FLEMING T
    Antimicrob Agents Chemother (Bethesda); 1964; 10():268-73. PubMed ID: 14287942
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECTIVENESS OF AMPICILLIN AGAINST GRAM-NEGATIVE BACTERIA. IN VITRO AND IN VIVO STUDIES OF A NEW ANTIBIOTIC.
    ANDERSON KN; KENNEDY RP; PLORDE JJ; SHULMAN JA; PETERSDORF RG
    JAMA; 1964 Feb; 187():555-61. PubMed ID: 14089001
    [No Abstract]   [Full Text] [Related]  

  • 3. SPONTANEOUS PROTEUS MIRABILIS INFECTION ASSOCIATED WITH CHRONIC DIARRHEA IN A RHESUS MONKEY (MACACA MULATTA): (A CASE REPORT).
    POVAR ML
    Lab Anim Care; 1965 Aug; 15():262-3. PubMed ID: 14341172
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro sensitivity of Bacillus proteus and Pseudomonas aeruginosa to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin.
    FRANK PF; WILCOX C; FINLAND M
    J Lab Clin Med; 1950 Feb; 35(2):205-14. PubMed ID: 15404235
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDIES ON THE ETIOLOGY OF GASTROENTEROCOLITIS IN EARLY INFANCY AND CHILDHOOD. III. STUDY ON THE ROLE OF PROTEUS VULGARIS AND PROTEUS MIRABILIS STRAINS].
    UJVARY G; LANYI B; GREGACS M; VOEROES S; ANGYAL T; PALL G
    Acta Microbiol Acad Sci Hung; 1963-1964; 10():315-26. PubMed ID: 14165349
    [No Abstract]   [Full Text] [Related]  

  • 6. First report in Africa of two clinical isolates of Proteus mirabilis carrying Salmonella genomic island (SGI1) variants, SGI1-PmABB and SGI1-W.
    Soliman AM; Ahmed AM; Shimamoto T; El-Domany RA; Nariya H; Shimamoto T
    Infect Genet Evol; 2017 Jul; 51():132-137. PubMed ID: 28359833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity of different Proteus species to antibiotics].
    Dikiĭ BN
    Antibiotiki; 1971 Jul; 16(7):622-4. PubMed ID: 4945575
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of certain antibiotics and antibiotic combinations against Proteus mirabilis with demonstration of in vitro synergism and antagonism.
    KAYE D; KOENIG MG; HOOK EW
    Am J Med Sci; 1961 Sep; 242():320-30. PubMed ID: 13752039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of laboratory data in the choice of antibiotics for the treatment of infections caused by microbes of the genus Proteus].
    Kuznetsova SM; Fomina IP
    Antibiotiki; 1969 May; 14(5):422-6. PubMed ID: 4891716
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region.
    Ahmed AM; Hussein AI; Shimamoto T
    J Antimicrob Chemother; 2007 Feb; 59(2):184-90. PubMed ID: 17114173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SYNERGISTIC EFFECT OF ANTIMICORBIAL PREPARATIONS ON PROTEUS].
    CHERNOMORDIK AB; LUKACH IG; SHAVORSKAIA LD
    Antibiotiki; 1963 Nov; 8():1031-3. PubMed ID: 14160057
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of endocarditis due to Proteus species: a literature review.
    Kalra A; Cooley C; Tsigrelis C
    Int J Infect Dis; 2011 Apr; 15(4):e222-5. PubMed ID: 21237686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro effect on Eberthella typhi of chloramphenicol combined with other antibiotics (penicillin, streptomycin and aureomycin].
    D'AGATA A; CARDILLO G
    Rass Medica; 1951 Jan; 28(1):15-7. PubMed ID: 14816595
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake pathways of clinical isolates of Proteus mirabilis into human epithelial cell lines.
    Oelschlaeger TA; Tall BD
    Microb Pathog; 1996 Jul; 21(1):1-16. PubMed ID: 8827702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the properties of Proteus under the effect of antibiotics. II. Effect of synthomycin on the properties of the causative agent & the course of experimental wound infection caused by synthomycin-sensitive & synthomycin-resistant Proteus forms].
    KUTDUSOVA KhA
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Jun; 30(6):35-40. PubMed ID: 13676832
    [No Abstract]   [Full Text] [Related]  

  • 16. [PROTEUS VULGARIS SEPTICEMIA: SEVERE COMPLICATIONS OF A LEG ULCER].
    BEUREY J; DUREUX JB; WEBER M; DRUESNE M; PETITJEAN J
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():239-42. PubMed ID: 14188382
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined activity of ampicillin with streptomycin or chloramphenicol against Pseudomonas aeruginosa.
    Ghobashy AA; Chiori CO
    Arzneimittelforschung; 1984; 34(3):255-7. PubMed ID: 6428424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the mode of action of aureomycin and mexocine in Proteus mirabilis].
    GUILLAUME J; OSTEUX R; WATTEL F; DESCHAMPS F
    C R Seances Soc Biol Fil; 1962; 156():1829-32. PubMed ID: 13963406
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the effect of penicillin and of other antibiotics on L forms of Proteus mirabilis].
    HOROSZEWICZ A; HOROSZEWICZ J
    Acta Microbiol Pol (1952); 1956; 5(1-2):9-14. PubMed ID: 13394215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.